de Burgh S G, Emery D L
The University of Sydney, Sydney, New South Wales, 2006, Australia.
Aust Vet J. 2025 Jun;103(6):322-329. doi: 10.1111/avj.13415. Epub 2025 Jan 10.
The aim of this non-blinded, randomised, controlled study was to determine the efficacy of toltrazuril for the prevention of oriental theileriosis in calves. Thirty calves were infected with Theileria orientalis Ikeda genotype through the application and retention of infected female bush ticks (Haemaphysalis longicornis). 15 Group 1 calves were treated with a single, oral dose of toltrazuril at the dose registered in Australia for coccidiosis (15 mg/kg), concurrently with tick infection, and 15 Group 2 (control group) calves were untreated. There were no significant differences (P > 0.05) in mean parasitaemia, packed cell volume (PCV) or bodyweight between the toltrazuril treated and untreated groups at any timepoint up to Day 64 after infection, apart from a higher mean PCV for the toltrazuril treated group at Day 20. In this study, the calves treated with a single oral dose of toltrazuril (15 mg/kg) at the time of infection were not prevented from becoming infected with oriental theileriosis.
这项非盲法随机对照研究的目的是确定托曲珠利预防犊牛东方泰勒虫病的疗效。通过应用并留置感染的雌性丛林蜱(长角血蜱),使30头犊牛感染东方泰勒虫池田基因型。第1组的15头犊牛在感染蜱虫的同时,按照澳大利亚登记的用于球虫病的剂量(15毫克/千克)口服单剂量托曲珠利,第2组(对照组)的15头犊牛不进行治疗。在感染后第64天之前的任何时间点,托曲珠利治疗组和未治疗组之间的平均虫血症、红细胞压积(PCV)或体重均无显著差异(P>0.05),但在第20天时,托曲珠利治疗组的平均红细胞压积较高。在本研究中,感染时口服单剂量托曲珠利(15毫克/千克)的犊牛未能预防感染东方泰勒虫病。